ERP and QMS Validation in Pharma: Scoping a Platform That Does More Than GMP

ERP and electronic quality management systems are large, configurable platforms where only part of the functionality is GxP relevant. The skill in validating them is drawing the scope line in the right place and defending it.

Scope by process, not by module

An ERP system supports finance, procurement and sales alongside material status, batch genealogy, inventory and release. A QMS holds deviations, CAPA, change control, complaints and training records. Rather than validating everything or nothing, list the business processes with a GMP, GDP or pharmacovigilance impact, and assess each for its effect on product quality, patient safety and data integrity. The rationale should be written down, because an inspector may ask why a function was left out.

Focus testing on high-impact functions

For an ERP, the GxP-critical areas tend to be:

  • Material and batch status, quarantine and release controls, so that unreleased stock cannot be consumed or shipped
  • Batch traceability from raw material to customer
  • Expiry and retest date handling, and first-expired-first-out logic
  • Master data control, including who may create or change materials and suppliers
  • Interfaces to MES, laboratory and warehouse systems

For a QMS, the emphasis falls on workflow rules, mandatory fields, escalation and due-date logic, electronic signatures, and links between records such as a deviation, its CAPA and the resulting change.

Use the supplier, but do not outsource accountability

Vendor testing and platform documentation can reduce your effort, particularly for standard functionality, provided you have assessed the supplier and understand what was tested. Configuration, custom code, reports and interfaces remain your responsibility. This is especially true for cloud-hosted platforms, where releases arrive on the vendor’s schedule and must be assessed through your own change control.

Plan for the data you already have

Implementations usually involve migrating data from older systems. Annex 11 expects validation to include checks that data are not altered in value or meaning during migration, so plan reconciliation, sampling and acceptance criteria early rather than at cut-over.

Linking the work to your quality system

Validation does not stand alone. Risk assessments should feed change control, deviations on the system should be trended, supplier audits should inform the scope of testing, and periodic review should confirm that the documentation still describes reality. When these links are visible, the computerised system becomes part of the pharmaceutical quality system rather than a separate project, and the evidence you present at inspection reads as one coherent picture.

How PQRA helps

PQRA helps companies define the GxP scope of ERP and QMS projects, write the rationale for risk-based testing, assess suppliers, and plan data migration verification. We can also review existing documentation to see whether it would withstand questions at inspection.

Contact PQRA to discuss your computerised systems and data governance programme.

CATEGORIES:

Uncategorized

Tags:

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *